Thymus Neoplasms Clinical Trial
Official title:
Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection-Single Center Phase II Single Arm Clinical Trial
The purpose of this study is to evaluate the efficiency and toxicity of adjuvant hypofractionation radiotherapy for thymic epithelial tumours after complete resection.
Adjuvant Radiotherapy(Postoperative radiotherapy) is proposed in stage II and III thymic carcinoma，stage III thymoma，stage IIB B2/B3 thymomas. Hypofractionation Radiotherapy is used in this study. The purpose of this study is to evaluate the efficiency and toxicity of adjuvant hypofractionation radiotherapy for thymic epithelial tumours after complete resection. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00921739 -
Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies
|
Phase 1 | |
| Recruiting |
NCT05918302 -
Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.
|
Phase 3 | |
| Active, not recruiting |
NCT01621568 -
Sunitinib for Advanced Thymus Cancer Following Earlier Treatment
|
Phase 2 | |
| Withdrawn |
NCT01610544 -
18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma
|
Phase 2 | |
| Active, not recruiting |
NCT02364076 -
Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma
|
Phase 2 | |
| Terminated |
NCT02859415 -
Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases
|
Phase 1/Phase 2 | |
| Completed |
NCT00591981 -
Thoracic OncoGeriatric Assessment (TOGA) Trials
|
||
| Recruiting |
NCT04822077 -
Study on Proton Radiotherapy of Thymic Malignancies
|
N/A |